- About Progeria
- About PRF
- Meet the Kids
- Medical Research
- Parents & Doctors
- Get Involved
- Fundraising Events
- Contact Us
- Donate Now
of the Planning Committee
Leslie B. Gordon, MD, PhD – Chair,
Scientific Advisory Committee; Organizing Committee
Associate Professor of Pediatrics Research, Warren Alpert Medical School of Brown University and Dept. of Pediatrics, Hasbro Children’s Hospital, Providence, RI; Medical Director, The Progeria Research Foundation, Peabody, MA; Staff Scientist, Department of Anesthesia, Children’s Hospital Boston and Harvard Medical School, Boston, MA
Dr. Gordon, founder of The Progeria Research Foundation (PRF), and co-author of the Progeria gene discovery has served as Chair of seven previous scientific meetings on Progeria since PRF’s inception in 1999. She serves as Principal Investigator for The Progeria Research Foundation International Registry, Diagnostic Testing Program, Cell & Tissue Bank, and Medical & Research Database. Dr. Gordon has co-Chaired three clinical treatment trials for children with Progeria, all conducted at Boston Children’s Hospital.
Gordon, Esq. – Chair, Organizing Committee
President and Executive Director, The Progeria Research Foundation, Peabody, MA
Attorney Gordon, co-founder of The Progeria Research Foundation, is responsible for ensuring PRF’s financial growth, program development, and day-to-day management. She has been the project administrator for all seven PRF international scientific meetings on Progeria.
Frank G. Rothman, PhD – Scientific
Advisory Committee, Organizing Committee
Professor of Biology and Provost, Emeritus, Brown University, Providence, RI
Dr. Rothman has served as the Dean of Biology at Brown University and conducted courses on the Biology of Aging. He has co-coordinated four previous Progeria Research Foundation scientific workshops, and is an active member of PRF’s Medical Research Committee.
Lopez-Otin, PhD – Scientific Advisory Committee
Professor of Biochemistry and Molecular Biology, Medical School of Oviedo University, Oviedo, Spain.
group has created mouse models of Progeria that have been pivotal for studying
the biology of disease and its overlaps with aging. He has discovered that the premature aging
phenotype of these mice can be rescued by using genetic and pharmacological
approaches. His breakthrough studies have demonstrated new therapeutic
approaches for devastating human progeroid syndromes.
Thomas Misteli, PhD – Scientific
Senior Investigator and Head, Cell Biology of Genomes Group,National Cancer Institute, National Institutes of Health, Bethesda, MD
Dr. Misteli and his team are elucidating the cell biological basis of HGPS and are developing novel therapeutic strategies for HGPS based on correction of the disease causing pre-mRNA splicing defect.
Maria Sullivan – Organizing Committee
CME Director, Office of Continuing Medical Education, The Warren Alpert Medical School of Brown University, Providence, RI
The Alpert Medical School is accredited by the Accreditation Council for Continuing Medical Education to sponsor quality educational activities for physicians. The Office of Continuing Medical Education plans and implements CME activities in accordance with the ACCME Essential Areas and policies and Standards for Commercial Support.
Gina Ragonese – Meeting Coordinator
Administrative Assistant, The Progeria Research Foundation, Peabody, MA,
Ms. Ragonese joined the PRF team in June 2012. She has extensive event planning experience, and can be reached at firstname.lastname@example.org or 978-535-2594 for all workshop-related matters.